Overview
development of reagents for protein and peptide radioiodination that decrease deiodination in vivo by up to 100-fold, b) demonstration that At-211 labeled monoclonal antibodies are effective in the treatment of a rat model of neoplastic meningitis, c) synthesis of a thymidine analogue labeled with At-211 and the demonstration that this molecule is taken up in cellular DNA with highly cytotoxicity even at levels of only one atom bound per cell and d) development of
radiohalobenzylguanidines which are specifically cytotoxic for human neuroblastoma cells.
Current Appointments & Affiliations
Jonathan Spicehandler, M.D. Distinguished Professor of Neuro Oncology, in the School of Medicine
·
2008 - Present
Radiology,
Clinical Science Departments
Professor of Radiology
·
2018 - Present
Radiology,
Clinical Science Departments
Professor of Radiation Oncology
·
2009 - Present
Radiation Oncology,
Clinical Science Departments
Professor in Pathology
·
2017 - Present
Pathology,
Clinical Science Departments
Professor of Biomedical Engineering
·
2024 - Present
Biomedical Engineering,
Pratt School of Engineering
Member of the Duke Cancer Institute
·
1985 - Present
Duke Cancer Institute,
Institutes and Centers
Education, Training & Certifications
Washington University in St. Louis ·
1974
Ph.D.
Washington University in St. Louis ·
1972
M.A.